PEGylated Lipid Polymeric Nanoparticle–Encapsulated Acyclovir for In Vitro Controlled Release and Ex Vivo Gut Sac Permeation

Currently, pharmaceutical research is directed wide range for developing new drugs for oral administration to target disease. Acyclovir formulation is having common issues of short half-life and poor permeability, causing messy treatment which results in patient incompliance. The present study formu...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahmood, Syed, Kiong, Kong Chak, Tham, Chun Shern, Chien, Tan Choo, Hilles, Ayah Rebhi, Venugopal, Jayarama Reddy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556614/
https://www.ncbi.nlm.nih.gov/pubmed/33057878
http://dx.doi.org/10.1208/s12249-020-01810-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556614/
https://www.ncbi.nlm.nih.gov/pubmed/33057878
http://dx.doi.org/10.1208/s12249-020-01810-0

Ejemplares similares